Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Opat

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Haematology|January 19, 2023
High risk of infection in 'real-world' patients receiving ibrutinib, idelalisib or venetoclax for mature B-cell leukaemia/lymphomaAmanda Tey, James Schwarer, Robert Raffa, et al.
Blood|August 23, 2007
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemiaAlberto Catalano, Mark A Dawson, Karthiga Somana, et al.
Scientific Reports|July 2, 2017
Infection is an Independent Predictor of Death in Diffuse Large B Cell LymphomaClaire Dendle, Michael Gilbertson, Tim Spelman, et al.
British Journal of Haematology|June 15, 2022
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemiaStephen P Mulligan, Stephen Opat, Paula Marlton, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.
Heart, Lung & Circulation|February 23, 2007
Antioxidant therapy for severe cardiac failure induced by iron overload secondary to dyserythropoietic anaemiaJuliana van der Merwe, Jee-Yoong Leong, David Kaye, et al.
Ejhaem|January 31, 2025
Real-World Data on Lymphoma in Adolescents and Young Adults (AYA)-Report From the Lymphoma and Related Diseases Registry (LaRDR)Evangeline Y Wong, Cameron Wellard, Jun Yen Ng, et al.
Internal Medicine Journal|January 19, 2021
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm studySant-Rayn Pasricha, Michael Gilbertson, Tishya Indran, et al.
Blood Advances|February 8, 2023
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemiaConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Hemasphere|September 28, 2022
COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE StudyCarsten U Niemann, Farrukh T Awan, Laura Fogliatto, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|January 19, 2023
High risk of infection in 'real-world' patients receiving ibrutinib, idelalisib or venetoclax for mature B-cell leukaemia/lymphomaAmanda Tey, James Schwarer, Robert Raffa, et al.
Blood|August 23, 2007
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemiaAlberto Catalano, Mark A Dawson, Karthiga Somana, et al.
Scientific Reports|July 2, 2017
Infection is an Independent Predictor of Death in Diffuse Large B Cell LymphomaClaire Dendle, Michael Gilbertson, Tim Spelman, et al.
British Journal of Haematology|June 15, 2022
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemiaStephen P Mulligan, Stephen Opat, Paula Marlton, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.
Heart, Lung & Circulation|February 23, 2007
Antioxidant therapy for severe cardiac failure induced by iron overload secondary to dyserythropoietic anaemiaJuliana van der Merwe, Jee-Yoong Leong, David Kaye, et al.
Ejhaem|January 31, 2025
Real-World Data on Lymphoma in Adolescents and Young Adults (AYA)-Report From the Lymphoma and Related Diseases Registry (LaRDR)Evangeline Y Wong, Cameron Wellard, Jun Yen Ng, et al.
Internal Medicine Journal|January 19, 2021
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm studySant-Rayn Pasricha, Michael Gilbertson, Tishya Indran, et al.
Blood Advances|February 8, 2023
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemiaConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Hemasphere|September 28, 2022
COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE StudyCarsten U Niemann, Farrukh T Awan, Laura Fogliatto, et al.
Pageof 13